| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.867 | 1.626 | 1.532 | 1.655 | 1.307 | 289 | 0 | 0 | 586 | 342 |
| Total Income - EUR | 1.867 | 1.626 | 1.532 | 1.655 | 1.307 | 289 | 20 | 0 | 586 | 342 |
| Total Expenses - EUR | 537 | 192 | 92 | 168 | 169 | 93 | 12 | 0 | 0 | 332 |
| Gross Profit/Loss - EUR | 1.330 | 1.434 | 1.440 | 1.487 | 1.138 | 196 | 8 | 0 | 586 | 10 |
| Net Profit/Loss - EUR | 1.274 | 1.385 | 1.394 | 1.437 | 1.099 | 188 | 8 | 0 | 492 | 8 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Acupunctura Si Biokinezie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 8.173 | 9.473 | 10.708 | 12.002 | 12.868 | 12.812 | 12.537 | 12.575 | 1.831 | 1.831 |
| Inventories | 489 | 484 | 476 | 467 | 458 | 450 | 440 | 441 | 440 | 437 |
| Receivables | 7.038 | 7.795 | 8.517 | 9.504 | 10.593 | 11.548 | 11.292 | 11.327 | 0 | 0 |
| Cash | 645 | 1.194 | 1.714 | 2.031 | 1.817 | 815 | 805 | 808 | 1.392 | 1.394 |
| Shareholders Funds | 7.411 | 8.720 | 9.967 | 11.222 | 12.103 | 12.062 | 11.802 | 11.839 | 1.083 | 1.086 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 762 | 753 | 740 | 780 | 765 | 751 | 735 | 737 | 748 | 746 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Acupunctura Si Biokinezie S.r.l.